Jurors award $47.5 million in Vioxx decision March 13, 2007 (Associated Press) – “Merck & Co.’s painkiller Vioxx contributed to an Idaho postal worker’s heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man’s first trial and hitting Merck with a total of $47.5 million in damages." Vioxx Recall : Drugmaker Merck & Co. pulled its best-selling arthritis drug Vioxx off the market on September 30, 2004, based on drug trial data indicating Vioxx increases the risk of heart attack and stroke among users. The Vioxx drug trial, called the APPROVe [Adenomatous Polyp Prevention on VIOXX] trial, compared Vioxx to a placebo (sugar-pill). The purpose of the trial was to see if 25 milligrams of Vioxx was effective in preventing the recurrence of colon polyps. The trial was stopped early because there was an increased risk for serious cardiovascular events, such as heart attacks and strokes. The increased risk was first observed after 18 months of continuous treatment in patients taking Vioxx. The patients taking the placebo did not indicate any increased risks.

If you, or a loved one, has taken Vioxx and suffered any side effects, the MEDLAW Legal Team can help protect your rights.

Our in-house legal team consists of a physician, five registered nurses, 13 attorneys, and more than 30 staff-members. As one of the nation's premier pharmaceutical liability law firms, we represent consumers nationwide who have been victimized by defective pharmaceutical drugs, including Vioxx.  We have the experience to protect your legal rights and to help you obtain the compensation you deserve.  If you or a loved one have suffered serious side effects from the use of Vioxx, please contact us for an immediate case evaluation.

Many law firms that advertise aggressively on the Internet are actually client brokers who refer virtually all clients to lawyers in other firms and other cities who do the actual work of representing the client. Janet, Jenner & Suggs, LLC, is a traditional law firm that actively represents all of our clients. Robert K. Jenner and Kenneth Suggs, leaders of the pharmaceutical department within the firm, will always be accessible to you. Mr. Jenner and Mr. Suggs, nationally recognized advocates on behalf of victims of defective pharmaceutical products, and their highly experienced team, will always be ready to answer your questions.